# Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO)

> **NCT01169402** · PHASE1 · COMPLETED · sponsor: **Michael Cohen-Wolkowiez** · enrollment: 21 (actual)

## Conditions studied

- Cardiopulmonary Arrest
- Fungal Infection

## Interventions

- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT01169402
- **Lead sponsor:** Michael Cohen-Wolkowiez
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2013-02-20
- **Final completion:** 2013-02-20
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01169402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01169402, "Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01169402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*